FourThought Financial Partners, LLC

Position in NVO — Novo Nordisk A S

CIK 1956790 VENICE, FL

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,895,105

+$1,462,692 QoQ

Shares Held

102,109

+9.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#224

of 1,348 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FourThought Financial Partners, LLC holds $48,924,367 across 10 Drug Manufacturers - General names. NVO ranks #4 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	80,917	$15,343,481
2	AMGN	Amgen Inc	32,361	$11,718,565
3	LLY	ELI LILLY & Co	5,899	$7,075,438
4	NVO	Novo Nordisk A S This page	102,109	$4,895,105
5	ABBV	AbbVie Inc.	17,032	$4,285,932
6	JNJ	Johnson & Johnson	14,967	$3,801,168
7	MRK	Merck & Co., Inc.	4,550	$584,675
8	GILD	Gilead Sciences, Inc.	3,418	$431,830

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,895,105	102,109	+9.3%	Shares	Sole	2026-08-12
2026-03-31	$3,432,413	93,399	+56.5%	Shares	Sole	2026-05-07
2025-12-31	$3,037,078	59,691	-4.6%	Shares	Sole	2026-02-06
2025-09-30	$3,470,733	62,547	+8.0%	Shares	Sole	2025-11-13
2025-06-30	$3,998,604	57,934	+641.4%	Shares	Sole	2025-08-12
2025-03-31	$542,604	7,814	+11.5%	Shares	Sole	2025-05-07
2024-12-31	$602,656	7,006	+1.1%	Shares	Sole	2025-02-04
2024-09-30	$825,155	6,930	+1.6%	Shares	Sole	2024-11-13
2024-06-30	$973,486	6,820	-0.8%	Shares	Sole	2024-08-13
2024-03-31	$882,878	6,876	+25.9%	Shares	Sole	2024-05-14
2023-12-31	$565,147	5,463	-1.8%	Shares	Sole	2024-02-13
2023-09-30	$505,717	5,561	+95.9%	Shares	Sole	2023-11-13
2023-06-30	$459,273	2,838	-21.7%	Shares	Sole	2023-08-11
2023-03-31	$576,882	3,625	-4.0%	Shares	Sole	2023-05-04
2022-12-31	$511,314	3,778	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.